81 related articles for article (PubMed ID: 11346361)
21. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
22. [A spontaneously resolving T-cell lymphoma].
Mutsaers ER; Willemze R; van Rossum MM
Ned Tijdschr Geneeskd; 2011; 155(45):A3930. PubMed ID: 22085572
[TBL] [Abstract][Full Text] [Related]
23. Chromosomal imbalances: a hallmark of tumour relapse in primary cutaneous CD30+ T-cell lymphoma.
Prochazkova M; Chevret E; Beylot-Barry M; Sobotka J; Vergier B; Delaunay M; Turmo M; Ferrer J; Kuglik P; Merlio JP
J Pathol; 2003 Nov; 201(3):421-9. PubMed ID: 14595754
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus in CD30 anaplastic large cell lymphoma involving the skin and lymphomatoid papulosis in South Korea.
Kim YC; Yang WI; Lee MG; Kim SN; Cho KH; Lee SJ; Lee MW; Koh JK
Int J Dermatol; 2006 Nov; 45(11):1312-6. PubMed ID: 17076712
[TBL] [Abstract][Full Text] [Related]
25. CD30+ anaplastic large cell lymphoma complicated by pyoderma gangrenosum with increased levels of serum cytokines.
Saito S; Yasui K; Hosoda W; Ogawa M; Kobayashi N; Sakashita K; Koike K
Eur J Haematol; 2006 Sep; 77(3):251-4. PubMed ID: 16923111
[TBL] [Abstract][Full Text] [Related]
26. A case of CD30+ nasal natural killer/T-cell lymphoma.
Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature.
Kumar S; Pittaluga S; Raffeld M; Guerrera M; Seibel NL; Jaffe ES
Pediatr Dev Pathol; 2005; 8(1):52-60. PubMed ID: 15719203
[TBL] [Abstract][Full Text] [Related]
28. Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma.
Mao X; Orchard G; Lillington DM; Russell-Jones R; Young BD; Whittaker S
Genes Chromosomes Cancer; 2003 Jun; 37(2):176-85. PubMed ID: 12696066
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
Benner MF; Jansen PM; Meijer CJ; Willemze R
Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
[TBL] [Abstract][Full Text] [Related]
30. Primary cutaneous CD30-positive anaplastic large cell lymphoma in a 16-year-old girl.
Kocabaş E; Türel Ermertcan A; Akinci S; Temiz P; Gündüz K
Int J Dermatol; 2012 Nov; 51(11):1353-8. PubMed ID: 21972869
[No Abstract] [Full Text] [Related]
31. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
Watanabe M; Sasaki M; Itoh K; Higashihara M; Umezawa K; Kadin ME; Abraham LJ; Watanabe T; Horie R
Cancer Res; 2005 Sep; 65(17):7628-34. PubMed ID: 16140928
[TBL] [Abstract][Full Text] [Related]
32. Relapse Pattern and Treatment Outcome of Curative Radiotherapy for Primary Cutaneous CD30+ Anaplastic Large-cell Lymphoma: A Retrospective Cohort Study.
Huang BS; Chen WY; Wang CW; Cheng AL; Hong JH; Kuo SH
Acta Derm Venereol; 2016 Mar; 96(3):394-5. PubMed ID: 26463467
[No Abstract] [Full Text] [Related]
33. Three children with CD30 cutaneous anaplastic large cell lymphomas bearing the t(2;5)(p23;q35) translocation.
Hinshaw M; Trowers AB; Kodish E; Kuerbitz S; Shurin S; Wood GS
Pediatr Dermatol; 2004; 21(3):212-7. PubMed ID: 15165197
[TBL] [Abstract][Full Text] [Related]
34. Peripheral blood identification of neoplastic cells and the tumoral growth fraction by double immunocytochemical study in a case of anaplastic CD30-positive large cell lymphoma.
Tarin F; Miguel-García A; Linares M; Sanchez M; Orero M; Hernández F; Blanquer A; Miguel-Sosa A; Carbonell F; Matutes E
Leukemia; 1996 Sep; 10(9):1560. PubMed ID: 8751482
[No Abstract] [Full Text] [Related]
35. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
36. Treatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapy.
Yu JB; McNiff JM; Lund MW; Wilson LD
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1542-5. PubMed ID: 18037577
[TBL] [Abstract][Full Text] [Related]
37. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.
Huebner-Chan D; Fernandes B; Yang G; Lim MS
Mod Pathol; 2001 Oct; 14(10):1000-7. PubMed ID: 11598170
[TBL] [Abstract][Full Text] [Related]
38. Large CD30-positive cells in benign, atypical lymphoid infiltrates of the skin.
Werner B; Massone C; Kerl H; Cerroni L
J Cutan Pathol; 2008 Dec; 35(12):1100-7. PubMed ID: 18616762
[TBL] [Abstract][Full Text] [Related]
39. Primary cutaneous anaplastic large cell lymphoma successfully treated with low-dose oral methotrexate.
Fujita H; Nagatani T; Miyazawa M; Wada H; Koiwa K; Komatsu H; Ikezawa Z
Eur J Dermatol; 2008; 18(3):360-1. PubMed ID: 18474486
[No Abstract] [Full Text] [Related]
40. [Respiratory manifestations of carbamazepine. Apropos of a case].
Ben Jemaa M; Kammoun S; Kanoun F; Zghal KM; Ben Hamed S
Rev Pneumol Clin; 1997; 53(6):351-4. PubMed ID: 9616832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
